Moderate alcohol intake generally does not interfere with Filistra’s effectiveness, but excessive drinking can diminish erection quality and increase the risk of dizziness or low blood pressure. It is advisable to limit alcohol consumption when planning sexual activity.
A prolonged erection (priapism) is a medical emergency. Seek immediate care at an emergency department; prompt treatment reduces the risk of permanent tissue damage.
All PDE5 inhibitors share the same core mechanism-blocking the PDE5 enzyme. Differences lie in onset, duration, and dosing flexibility. Filistra (vardenafil) typically has a quicker onset (≈30 minutes) and a shorter duration (≈4-5 hours) compared with some alternatives.
Filistra can be used by men with well-controlled hypertension. Uncontrolled high blood pressure or severe cardiovascular disease requires evaluation by a healthcare professional before initiating therapy.
A high-fat meal may delay the drug’s absorption, leading to a slower onset of action. Taking Filistra on an empty stomach or after a light meal provides more predictable timing.
Filistra is intended for use on an as-needed basis, typically once per day, at least 30 minutes before sexual activity. Daily dosing without a specific medical reason is not recommended.
Filistra tablets are round, film-coated, and come in three strengths: 10 mg (white), 20 mg (blue), and 40 mg (orange). Imprint codes vary by manufacturer and batch.
Routine laboratory testing is not required for standard use. However, men with liver or kidney impairment may need periodic assessment of organ function as directed by their clinician.
Yes. Vardenafil, the active ingredient in Filistra, has been evaluated and approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of erectile dysfunction.
When travelling, keep the medication in its original packaging, carry a copy of the prescription, and be aware of the destination country’s regulations regarding prescription drugs. Declare the medication at customs if required.
Filitra contains vardenafil as its active ingredient. Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that belongs to the therapeutic class of erectile dysfunction (ED) medications. Filitra is supplied as an oral pill and is available in the United Kingdom in 10 mg, 20 mg, and 40 mg strengths. It is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Vardenafil inhibits the PDE5 enzyme found in the smooth muscle of the penis. By blocking this enzyme, it prevents the breakdown of cyclic guanosine monophosphate (cGMP), a molecule that promotes relaxation of smooth muscle and increased blood flow. When sexual stimulation releases nitric oxide, cGMP levels rise, leading to an erection. Vardenafil’s onset of action is typically within 30 minutes, peak effect occurs at about 1 hour, and the duration of effect can last up to 4-5 hours. The drug is absorbed orally, reaches peak plasma concentrations in 30-120 minutes, and is metabolised primarily by the liver enzyme CYP3A4.
Filistra is approved in the United Kingdom for the treatment of erectile dysfunction in adult men. It is indicated for men who have difficulty achieving or maintaining an erection sufficient for satisfactory sexual performance. The medication is not approved for use in women, children, or for other medical conditions.
These reactions are usually mild, transient, and do not require medical intervention unless they persist.
Routine laboratory monitoring is not required for most patients. However, men with known cardiovascular disease should have a recent cardiac evaluation to confirm that sexual activity is medically appropriate. If any serious side effect or unexpected reaction occurs, immediate medical assessment is advised.
This article provides educational information about Filistra and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
